Headline News about Lemaitre Vascular
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
October 28, 2022
Via Benzinga
Lemaitre Vascular Inc (LMAT) Q3 2021 Earnings Call Transcript
October 29, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
Via Benzinga
The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
June 18, 2021
Via Benzinga
Exposures
Product Safety
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|